Literature DB >> 33619080

Using viral load and epidemic dynamics to optimize pooled testing in resource-constrained settings.

Brian Cleary1, James A Hay2,3, Brendan Blumenstiel4, Maegan Harden4, Michelle Cipicchio4, Jon Bezney4, Brooke Simonton4, David Hong5, Madikay Senghore6, Abdul K Sesay7, Stacey Gabriel4, Aviv Regev8,9,10,11, Michael J Mina1,6,3,12.   

Abstract

Virological testing is central to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) containment, but many settings face severe limitations on testing. Group testing offers a way to increase throughput by testing pools of combined samples; however, most proposed designs have not yet addressed key concerns over sensitivity loss and implementation feasibility. Here, we combined a mathematical model of epidemic spread and empirically derived viral kinetics for SARS-CoV-2 infections to identify pooling designs that are robust to changes in prevalence, and to ratify sensitivity losses against the time course of individual infections. We show that prevalence can be accurately estimated across a broad range, from 0.02% to 20%, using only a few dozen pooled tests, and using up to 400 times fewer tests than would be needed for individual identification. We then exhaustively evaluated the ability of different pooling designs to maximize the number of detected infections under various resource constraints, finding that simple pooling designs can identify up to 20 times as many true positives as individual testing with a given budget. We illustrate how pooling affects sensitivity and overall detection capacity during an epidemic and on each day post infection, finding that only 3% of false negative tests occurred when individuals are sampled during the first week of infection following peak viral load, and that sensitivity loss is mainly attributable to individuals sampled at the end of infection when detection for limiting transmission has minimal benefit. Crucially, we confirmed that our theoretical results can be translated into practice using pooled human nasopharyngeal specimens by accurately estimating a 1% prevalence among 2,304 samples using only 48 tests, and through pooled sample identification in a panel of 960 samples. Our results show that accounting for variation in sampled viral loads provides a nuanced picture of how pooling affects sensitivity to detect infections. Using simple, practical group testing designs can vastly increase surveillance capabilities in resource-limited settings.
Copyright © 2021, American Association for the Advancement of Science.

Entities:  

Year:  2021        PMID: 33619080     DOI: 10.1126/scitranslmed.abf1568

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  13 in total

1.  Heterogeneous adaptive behavioral responses may increase epidemic burden.

Authors:  Baltazar Espinoza; Samarth Swarup; Christopher L Barrett; Madhav Marathe
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

2.  Singleplex, multiplex and pooled sample real-time RT-PCR assays for detection of SARS-CoV-2 in an occupational medicine setting.

Authors:  Kimberly S Butler; Bryan D Carson; Joshua D Podlevsky; Cathryn M Mayes; Jessica M Rowland; DeAnna Campbell; J Bryce Ricken; George Wudiri; Jerilyn A Timlin
Journal:  Sci Rep       Date:  2022-10-22       Impact factor: 4.996

3.  Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools - a cluster randomised trial.

Authors:  Alexander Joachim; Felix Dewald; Isabelle Suárez; Michael Zemlin; Isabelle Lang; Regine Stutz; Anna Marthaler; Hans Martin Bosse; Nadine Lübke; Juliane Münch; Marie-Annett Bernard; Kathrin Jeltsch; Burkhard Tönshoff; Niklas Weidner; Hans-Georg Kräusslich; Lena Birzele; Johannes Hübner; Patricia Schmied; Melanie Meyer-Bühn; Gibran Horemheb-Rubio; Oliver A Cornely; Heinz Haverkamp; Gerhard Wiesmüller; Gerd Fätkenheuer; Barbara Hero; Rolf Kaiser; Jörg Dötsch; Jan Rybniker
Journal:  EClinicalMedicine       Date:  2021-08-25

4.  Modeling for COVID-19 college reopening decisions: Cornell, a case study.

Authors:  Peter I Frazier; J Massey Cashore; Ning Duan; Shane G Henderson; Alyf Janmohamed; Brian Liu; David B Shmoys; Jiayue Wan; Yujia Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-11       Impact factor: 11.205

5.  The Positive Rate of Nucleic Acid Testing and the Epidemiological Characteristics of COVID-19 in Chongqing.

Authors:  Xiaohua Liang; Yajun Sun; Lun Xiao; YanLing Ren; Xian Tang
Journal:  Front Med (Lausanne)       Date:  2022-01-14

6.  Safe and effective pool testing for SARS-CoV-2 detection.

Authors:  Marie Wunsch; Dominik Aschemeier; Eva Heger; Denise Ehrentraut; Jan Krüger; Martin Hufbauer; Adnan S Syed; Gibran Horemheb-Rubio; Felix Dewald; Irina Fish; Maike Schlotz; Henning Gruell; Max Augustin; Clara Lehmann; Rolf Kaiser; Elena Knops; Steffi Silling; Florian Klein
Journal:  J Clin Virol       Date:  2021-10-28       Impact factor: 3.168

Review 7.  Diagnostic Techniques for COVID-19: A Mini-review of Early Diagnostic Methods.

Authors:  Gao-Pan Dong; Xiu-Juan Guo; Ying-Ai Sun; Zheng Zhang; Lu-Pei Du; Min-Yong Li
Journal:  J Anal Test       Date:  2021-10-04

8.  Quantifying the Impact of Nasopharyngeal Specimen Quality on Severe Acute Respiratory Syndrome Coronavirus 2 Test Performance.

Authors:  Melissa Richard-Greenblatt; Matthew J Ziegler; Valerie Bromberg; Elizabeth Huang; Hatem Abdallah; Pam Tolomeo; Ebbing Lautenbach; Laurel Glaser; Brendan J Kelly
Journal:  Open Forum Infect Dis       Date:  2021-05-12       Impact factor: 4.423

9.  Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.

Authors:  Stephen M Kissler; Joseph R Fauver; Christina Mack; Scott W Olesen; Caroline Tai; Kristin Y Shiue; Chaney C Kalinich; Sarah Jednak; Isabel M Ott; Chantal B F Vogels; Jay Wohlgemuth; James Weisberger; John DiFiori; Deverick J Anderson; Jimmie Mancell; David D Ho; Nathan D Grubaugh; Yonatan H Grad
Journal:  PLoS Biol       Date:  2021-07-12       Impact factor: 9.593

Review 10.  Nucleic Acid Testing of SARS-CoV-2.

Authors:  Hee Min Yoo; Il-Hwan Kim; Seil Kim
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.